Cash from Investing (Quarterly) Chart

Historical Cash from Investing (Quarterly) Data

View and export this data back to 2006. Start Trial.
Date Value
June 30, 2026 -0.774M
March 31, 2026 -0.9933M
December 31, 2025 -5.495M
September 30, 2025 -2.053M
June 30, 2025 -6.600M
March 31, 2025 -0.5925M
December 31, 2024 -0.8393M
September 30, 2024 -0.8842M
June 30, 2024 -0.51M
March 31, 2024 -1.371M
December 31, 2023 -0.4728M
September 30, 2023 -2.532M
June 30, 2023 -0.825M
March 31, 2023 -1.420M
December 31, 2022 -0.0235M
September 30, 2022 -2.128M
June 30, 2022 -2.140M
March 31, 2022 0.1772M
December 31, 2021 24.34M
September 30, 2021 -0.243M
June 30, 2021 -0.4156M
March 31, 2021 -0.1253M
December 31, 2020 -0.1993M
September 30, 2020 -0.2231M
June 30, 2020 0.2181M
Date Value
March 31, 2020 -0.1223M
December 31, 2019 -0.7784M
September 30, 2019 -0.3124M
June 30, 2019 -0.1708M
March 31, 2019 -0.2941M
December 31, 2018 -0.9083M
September 30, 2018 1.966M
June 30, 2018 0.3311M
March 31, 2018 -0.4621M
December 31, 2017 -7.620M
September 30, 2017 -0.6445M
June 30, 2017 -6.995M
March 31, 2017 -0.2377M
December 31, 2016 -0.6962M
September 30, 2016 0.5078M
June 30, 2016 -0.1897M
March 31, 2016 -0.2933M
December 31, 2015 -0.2222M
September 30, 2015 -0.7047M
June 30, 2015 -3.726M
March 31, 2015 -0.6116M
December 31, 2014 -0.1224M
September 30, 2014 -0.1365M
June 30, 2014 -0.1604M
March 31, 2014 -0.1672M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Fresenius Medical Care AG -312.01M
Global Cord Blood Corp. --
Cryo-Cell International, Inc. -0.1808M
Rhön-Klinikum AG --
Cordlife Group Ltd. -1.838M